The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/13/2017 |
| Start Date: | February 11, 2014 |
| End Date: | January 31, 2021 |
| Contact: | Isis W Gayed, MD |
| Email: | isis.w.gayed@uth.tmc.edu |
| Phone: | 713-704-1789 |
To describe the changes seen on bone scan and correlate them with changes in relative
chemical biomarkers, patient's functional status and level of pain.
chemical biomarkers, patient's functional status and level of pain.
Inclusion Criteria:
- Prostate cancer patients scheduled for treatment with Radium-223.
Exclusion Criteria:
- Patients not completing their treatment regimen for any reason
We found this trial at
1
site
7000 Fannin St
Houston, Texas 77030
Houston, Texas 77030
(713) 500-4472
Phone: 713-704-1789
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
Click here to add this to my saved trials
